NO-mediated immunosuppression has been demonstrated in human prostate carcinoma by its inhibition of arginase 1 (ARG1) in T cells and diminished antitumoural activity of tumour-infiltrating lymphocytes (TILs) resulting from tyrosine nitration [217]. Here, ARG1 is linked to prostate carcinoma.